Prescription drug · ANDA
Klor-Con (potassium chloride) NDC 0245-0836
Potassium chloride 750 mg/1 · Tablet, Film coated, Extended release · Oral · Upsher-Smith Laboratories, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0245-0836-11 | 00245083611 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-0836-11)Marketed from Aug 15, 2025 | |
| 0245-0836-15 | 00245083615 | 500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0245-0836-15)Marketed from Aug 15, 2025 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Klor-Con
- Generic name (nonproprietary)
- potassium chloride
- Active ingredients
- Potassium chloride — 750 mg/1
- Dosage form
- Tablet, Film coated, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218979
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 0245-0836_ad0ecaea-8b55-4e39-a7ae-f7df5f206258SPL ID ad0ecaea-8b55-4e39-a7ae-f7df5f206258SPL set ID 4340c3f2-ecf8-44cd-9b69-217f543e24e2RxCUI 312529, 628953, 628958, 832718UNII 660YQ98I10UPC 0302450835110
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400245083611followed by a unit qualifier and the quantityPackage 00245-0836-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Klor-Con is indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. KLOR-CON is a potassium salt, indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 218979
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Potassium Chloride | Potassium chloride 600 mg/1 | Tablet, Extended releaseOral | Upsher-Smith Laboratories, LLC | 24979-229 |
| Klor-Conpotassium chloride | Potassium chloride 600 mg/1 | Tablet, Film coated, Extended releaseOral | Upsher-Smith Laboratories, LLC | 0245-0835 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | AvKARE | 42291-487 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | Upsher-Smith Laboratories, LLC | 24979-230 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | Northwind Health Company, LLC | 82868-111 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Extended releaseOral | Aphena Pharma Solutions - Tennessee, LLC | 71610-977 |